Solstein Capital LLC Grows Stock Holdings in CME Group Inc. $CME

Solstein Capital LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 35.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,108 shares of the financial services provider’s stock after buying an additional 287 shares during the quarter. Solstein Capital LLC’s holdings in CME Group were worth $305,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CME. GAMMA Investing LLC grew its holdings in shares of CME Group by 24.5% during the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock worth $1,859,000 after buying an additional 1,381 shares during the last quarter. Golden State Wealth Management LLC grew its holdings in shares of CME Group by 3,662.5% during the first quarter. Golden State Wealth Management LLC now owns 602 shares of the financial services provider’s stock worth $160,000 after buying an additional 586 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of CME Group by 5.7% during the first quarter. Sequoia Financial Advisors LLC now owns 10,569 shares of the financial services provider’s stock worth $2,804,000 after buying an additional 573 shares during the last quarter. Western Wealth Management LLC purchased a new position in shares of CME Group during the first quarter worth about $213,000. Finally, Diversified Trust Co purchased a new position in shares of CME Group during the first quarter worth about $278,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME stock opened at $269.54 on Monday. The firm has a 50 day moving average of $266.47 and a 200-day moving average of $271.90. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $97.14 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 6.65 and a beta of 0.41.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the firm earned $2.68 EPS. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Insider Activity at CME Group

In other news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Oppenheimer raised their price target on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Piper Sandler raised their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Keefe, Bruyette & Woods raised their price objective on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research report on Monday, October 13th. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Finally, Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and raised their price objective for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $284.53.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.